Laserfiche WebLink
3.lnvest in infrastructure or staffing at government or not-for-profit agencies to support <br />collaborative, cross-system coordination with the purpose of preventing <br />overprescribing, opioid misuse, or opioid overdoses, treating those with oUD and any <br />co-occurring suD/MH conditions, co-usage, and/or co-addiction, supporting them in <br />treatment or recovery, connecting them to care, or implementing other strategies to <br />abate the opioid epidernic described in this opioid abatement strategy list. <br />4' Provide resources to staff government oversight and management of opioid <br />abatement programs. <br />K. TRAINTNG <br />ln addition to the training referred to in various items above, support training to abate the <br />opioid epidemic through activities, programs, or strategies that may include, but are not <br />limited to, the following: <br />Provide funding for stafftraining or networking programs and services to irnprove the <br />capability of government, community, and not-for-profit entities to abate the opioid <br />crisis. <br />lnvest in infrastructure and staffing for collaborative cross-system coordination to <br />prevent opioid misuse, prevent overdoses, and treat those with ouD and any co- <br />occurring suD/MH conditions, co-usage, and/or co-addiction, or implement other <br />strategies to abate the opioid epidemic described in this opioid abatement strategy <br />list (e.g., health care, primary care, pharmacies, pDMps, etc.) <br />t. RESEARCH <br />Support opioid abatement research that may include, but is not limited to, the following: <br />L' Monitoring, surveillance, and evaluation of programs and strategies described in this <br />opioid abatement strategy list. <br />2. Research non-opioid treatment of chronic pain. <br />3. Research on improved service delivery for modalities such as SBIRT that demonstrate <br />promising but mixed results in populations vulnerable to opioid use disorders.4' Research on innovative supply-side enforcement efforts such as improved detection <br />of mail-based delivery of synthetic opioids, <br />5. Expanded research on swift/certain/fair models to reduce and deter opioid misuse <br />within criminal justice populations that build upon promising approaches used to <br />address other substances (e.g. Hawaii HOpE and Dakota 24/71.6. Research on expanded modalities such as prescription methadone that can expand <br />access to MAT. <br />1. <br />2.